Adjusted EBITDA, a non GAAP metric, was a loss of $456,000 compared to a positive EBITDA of $633,000 in the prior year Q1. Now looking at the balance sheet in more detail. As of March 31, 2024, OSS had cash, cash equivalents and marketable securities of $12,900,000 and total working capital of $34,300,000 compared to total cash and cash equivalents and marketable securities of $11,800,000 and total working capital of $30,600,000 on December 31, 2023. OSS had no borrowings outstanding on its $2,000,000 working revolving line of credit on March 31, 2024 and December 31, 2023, respectively. The company's Brecher operation had a consolidated balance outstanding on its term loan on March 31, 2024 of $1,400,000 down from $2,100,000 on December 31, 2023 $3,200,000 as of March 31, 2023.